Low A S, Taylor R B
School of Pharmacy, Robert Gordon University, Schoolhill, Aberdeen, UK.
J Chromatogr B Biomed Appl. 1995 Jan 20;663(2):225-33. doi: 10.1016/0378-4347(94)00459-i.
A separation of heroin, 6-monoacetylmorphine, codeine, pholcodine, dihydrocodeine and morphine using a 200 x 2 mm I.D., 3 microns silica column with dichloromethane-pentane-diethylamine-methanol mobile phase is described. Data on the determination of these compounds in a urine matrix based on this separation using a solid-phase pretreatment with Bond Elut Certify cartridges and nalorphine as an internal standard are shown. The compounds listed can be quantified at levels below that generally accepted as the cut-off level for the screening for opiates by enzyme immunoassay (EMIT) with detection limits for the different opiates ranging from 4 to 20 ng ml-1. Comparative data are shown of subject urine samples assayed for opiates by both the enzyme immunoassay and the proposed method. The utility of the method for the elimination of so-called false positives detected by EMIT due to the presence of medically prescribed and non-prescription opiates in urine is discussed.
描述了使用内径200×2mm、3微米硅胶柱,以二氯甲烷 - 戊烷 - 二乙胺 - 甲醇为流动相分离海洛因、6 - 单乙酰吗啡、可待因、福尔可定、二氢可待因和吗啡的方法。展示了基于此分离方法,使用Bond Elut Certify柱进行固相预处理并以烯丙吗啡作为内标,在尿液基质中测定这些化合物的数据。列出的这些化合物能够在低于酶免疫测定法(EMIT)筛查阿片类药物通常所接受的截止水平下进行定量,不同阿片类药物的检测限范围为4至20 ng/ml-1。给出了通过酶免疫测定法和所提出的方法对受试者尿液样本进行阿片类药物检测的对比数据。讨论了该方法在消除因尿液中存在医学处方和非处方阿片类药物而导致EMIT检测出现所谓假阳性方面的效用。